Jammu and Kashmir Ranks 17th Nationally in Cervical Cancer Cases, Reports 684 New Cases in 2023

Jammu and Kashmir Ranks 17th Nationally in Cervical Cancer Cases, Reports 684 New Cases in 2023

WhatsApp Group Join Now

DELHI: Jammu and Kashmir ranked 17th among all states and Union Territories in India for cervical cancer cases in 2023, with 684 new cases reported, according to data from the National Cancer Registry Programme. The region has witnessed a steady rise in cases over the past five years, increasing from 612 in 2019 to 684 in 2023. This upward trend highlights the growing burden of the disease and underscores the urgent need for enhanced preventive measures.

While Jammu and Kashmir’s numbers remain lower compared to severely affected states like Uttar Pradesh (10,825 cases) and West Bengal (6,119 cases), its ranking signals the necessity for sustained awareness and intervention efforts. In contrast, neighboring states such as Punjab and Himachal Pradesh reported 2,459 and 506 cases, respectively, while Ladakh recorded 17 cases.

The Government of India, under the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD), continues to extend financial and technical support to states and Union Territories, including Jammu and Kashmir, in the fight against cervical cancer. Key initiatives include the establishment of District NCD Clinics and Tertiary Care Cancer Centres, comprehensive screening services for women aged 30 and above, and awareness campaigns through events like National Cancer Awareness Day and World Cancer Day.

The persistent rise in cervical cancer cases in Jammu and Kashmir underscores the critical importance of preventive healthcare measures. Vaccination against the human papillomavirus (HPV), regular screenings, and improved access to treatment remain essential strategies. The government has reaffirmed its commitment to strengthening cancer care infrastructure and promoting early detection and intervention as crucial steps in reducing mortality rates associated with cervical cancer.

Leave a Comment